{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:39:04Z","timestamp":1761561544471,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1053\/j.ajkd.2011.02.387","type":"journal-article","created":{"date-parts":[[2011,6,18]],"date-time":"2011-06-18T12:03:32Z","timestamp":1308398612000},"page":"73-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Geographic Variation in Cardioprotective Antihypertensive Medication Usage in Dialysis Patients"],"prefix":"10.1053","volume":"58","author":[{"given":"James B.","family":"Wetmore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Mahnken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purna","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingjiang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward F.","family":"Ellerbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally K.","family":"Rigler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa I.","family":"Shireman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.ajkd.2011.02.387_bib1","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1093\/ndt\/gfp212","article-title":"Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS","volume":"24","author":"Lopes","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2011.02.387_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199803053381003","article-title":"The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension","volume":"338","author":"Estacio","year":"1998","journal-title":"N Engl J Med"},{"issue":"9169","key":"10.1053\/j.ajkd.2011.02.387_bib3","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ajkd.2011.02.387_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"issue":"9266","key":"10.1053\/j.ajkd.2011.02.387_bib5","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.1053\/j.ajkd.2011.02.387_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2011.02.387_bib7","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/jama.288.12.1491","article-title":"Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy","volume":"288","author":"Kjeldsen","year":"2002","journal-title":"JAMA"},{"issue":"9377","key":"10.1053\/j.ajkd.2011.02.387_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"issue":"9386","key":"10.1053\/j.ajkd.2011.02.387_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"issue":"20","key":"10.1053\/j.ajkd.2011.02.387_bib10","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1053\/j.ajkd.2011.02.387_bib11","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1001\/jama.292.23.2849","article-title":"Association between cardiovascular outcomes and antihypertensive drug treatment in older women","volume":"292","author":"Wassertheil-Smoller","year":"2004","journal-title":"JAMA"},{"issue":"14","key":"10.1053\/j.ajkd.2011.02.387_bib12","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1001\/jama.294.14.1794","article-title":"Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure","volume":"294","author":"Demers","year":"2005","journal-title":"JAMA"},{"issue":"9489","key":"10.1053\/j.ajkd.2011.02.387_bib13","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"issue":"23","key":"10.1053\/j.ajkd.2011.02.387_bib14","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2011.02.387_bib15","doi-asserted-by":"crossref","first-page":"H140","DOI":"10.1152\/ajpheart.00687.2008","article-title":"Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction","volume":"296","author":"Mohan","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"10.1053\/j.ajkd.2011.02.387_bib16","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1211\/jpp.61.09.0014","article-title":"Enhancement of amlodipine cardioprotection by quercetin in ischaemia\/reperfusion injury in rats","volume":"61","author":"Ahmed","year":"2009","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"10.1053\/j.ajkd.2011.02.387_bib17","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1046\/j.1523-1755.2002.00636.x","article-title":"Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study","volume":"62","author":"Foley","year":"2002","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2011.02.387_bib18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1523-1755.2004.00473.x","article-title":"Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect?","volume":"65","author":"Ishani","year":"2004","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2011.02.387_bib19","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1053\/j.ajkd.2003.08.028","article-title":"Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients","volume":"42","author":"Griffith","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"22","key":"10.1053\/j.ajkd.2011.02.387_bib20","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1001\/archinte.164.22.2465","article-title":"Beta-blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality","volume":"164","author":"Abbott","year":"2004","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2011.02.387_bib21","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1046\/j.1523-1755.2002.00355.x","article-title":"Calcium channel blocker use and mortality among patients with end-stage renal disease","volume":"61","author":"Kestenbaum","year":"2002","journal-title":"Kidney Int"},{"year":"2003","series-title":"USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States","key":"10.1053\/j.ajkd.2011.02.387_bib22"},{"year":"2006","series-title":"USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States","key":"10.1053\/j.ajkd.2011.02.387_bib23"},{"issue":"1","key":"10.1053\/j.ajkd.2011.02.387_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/ndt\/gfp396","article-title":"Considering health insurance: how do dialysis initiates with Medicaid coverage differ from persons without Medicaid coverage?","volume":"25","author":"Wetmore","year":"2010","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"10.1053\/j.ajkd.2011.02.387_bib25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archinte.163.5.525","article-title":"Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks","volume":"163","author":"Douglas","year":"2003","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2011.02.387_bib26","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.CIR.92.5.1326","article-title":"Nifedipine","volume":"92","author":"Furberg","year":"1995","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2011.02.387_bib27","series-title":"Generalized, Linear, and Mixed Models","first-page":"220","article-title":"Generalized Linear Mixed Models (GLMMs)","author":"McCulloch","year":"2001"},{"year":"2000","series-title":"Applied Logistic Regression","author":"Hosmer","key":"10.1053\/j.ajkd.2011.02.387_bib28"},{"key":"10.1053\/j.ajkd.2011.02.387_bib29","first-page":"745","article-title":"SAS\u00ae for Mixed Models","author":"Littell","year":"2006"},{"issue":"3","key":"10.1053\/j.ajkd.2011.02.387_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.ajkd.2008.07.037","article-title":"The ABCs of cardioprotection in dialysis patients: a systematic review","volume":"53","author":"Wetmore","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2011.02.387_bib32","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1053\/j.ajkd.2011.02.387_bib33","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.ki.5001657","article-title":"Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies","volume":"70","author":"Zannad","year":"2006","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2011.02.387_bib34","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/ajkd.2002.36340","article-title":"ACE inhibitors and survival of hemodialysis patients","volume":"40","author":"Efrati","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2011.02.387_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1067\/mhj.2002.125513","article-title":"Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease","volume":"144","author":"McCullough","year":"2002","journal-title":"Am Heart J"},{"issue":"2","key":"10.1053\/j.ajkd.2011.02.387_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0735-1097(03)00572-2","article-title":"Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction","volume":"42","author":"Berger","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1053\/j.ajkd.2011.02.387_bib37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1053\/j.ajkd.2005.10.009","article-title":"Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction","volume":"47","author":"Winkelmayer","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2011.02.387_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2007.04.015","article-title":"25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"50","author":"de Boer","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2011.02.387_bib39","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1046\/j.1523-1755.2002.00638.x","article-title":"Incident acute coronary syndromes in chronic dialysis patients in the United States","volume":"62","author":"Trespalacios","year":"2002","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2011.02.387_bib40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1440-1797.2003.00157.x","article-title":"Cardiovascular risk in dialysis patients: a comparison of risk factors and cardioprotective therapy between 1996 and 2001","volume":"8","author":"Chow","year":"2003","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"10.1053\/j.ajkd.2011.02.387_bib41","first-page":"161","article-title":"Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients","volume":"10","author":"Boger","year":"2005","journal-title":"Eur J Med Res"},{"issue":"5","key":"10.1053\/j.ajkd.2011.02.387_bib42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1042\/cs1030511","article-title":"Association of calcium channel blockers and mortality in haemodialysis patients","volume":"103","author":"Tepel","year":"2002","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10.1053\/j.ajkd.2011.02.387_bib43","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1053\/j.ajkd.2008.04.007","article-title":"Variability in reasons for hemodialysis catheter use by race, sex, and geography: findings from the ESRD Clinical Performance Measures Project","volume":"52","author":"Hopson","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2011.02.387_bib44","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1542-4758.2009.00396.x","article-title":"Hemodialysis access at initiation in the United States, 2005 to 2007: still \u201ccatheter first.\u201d","volume":"13","author":"Foley","year":"2009","journal-title":"Hemodial Int"},{"issue":"5, pt 2","key":"10.1053\/j.ajkd.2011.02.387_bib45","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1600-6143.2007.01785.x","article-title":"Geographic variability in access to primary kidney transplantation in the United States, 1996-2005","volume":"7","author":"Ashby","year":"2007","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2011.02.387_bib46","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1523-1755.2003.00105.x","article-title":"Impact of surgeon and surgical center characteristics on choice of permanent vascular access","volume":"64","author":"O'Hare","year":"2003","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2011.02.387_bib47","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1681\/ASN.2008060624","article-title":"Treatment center and geographic variability in pre-ESRD care associate with increased mortality","volume":"20","author":"McClellan","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2011.02.387_bib48","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s11255-009-9606-1","article-title":"Patterns of cardioprotective medication prescription in incident hemodialysis patients","volume":"41","author":"Sood","year":"2009","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2011.02.387_bib49","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(02)02063-6","article-title":"Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study","volume":"40","author":"Wong","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1053\/j.ajkd.2011.02.387_bib50","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.CIR.91.10.2573","article-title":"Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction","volume":"91","author":"Greenberg","year":"1995","journal-title":"Circulation"},{"issue":"20","key":"10.1053\/j.ajkd.2011.02.387_bib51","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1056\/NEJMra021498","article-title":"Heart failure","volume":"348","author":"Jessup","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2011.02.387_bib52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00005344-200307000-00019","article-title":"Long-term treatment with the beta-blocker carvedilol restores autonomic tone and responsiveness in patients with moderate heart failure","volume":"42","author":"Malfatto","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"issue":"10","key":"10.1053\/j.ajkd.2011.02.387_bib53","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jacc.2006.04.026","article-title":"AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1053\/j.ajkd.2011.02.387_bib54","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/archinte.163.19.2306","article-title":"Peripheral arterial disease: identification and implications","volume":"163","author":"Mohler","year":"2003","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1053\/j.ajkd.2011.02.387_bib55","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.1053\/j.ajkd.2011.02.387_bib56","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2215\/CJN.04101206","article-title":"Peripheral arterial disease: a guide for nephrologists","volume":"2","author":"DeLoach","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2011.02.387_bib57","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/ndt\/gfh280","article-title":"Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider","volume":"19","author":"Manley","year":"2004","journal-title":"Nephrol Dial Transplant"},{"year":"2005","series-title":"USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States","key":"10.1053\/j.ajkd.2011.02.387_bib58"},{"issue":"11","key":"10.1053\/j.ajkd.2011.02.387_bib59","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.2215\/CJN.08170910","article-title":"CMS 2728: what good is it?","volume":"5","author":"Eggers","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5(suppl 2","key":"10.1053\/j.ajkd.2011.02.387_bib60","first-page":"68","article-title":"How good are the data?","volume":"20","year":"1992","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"10.1053\/j.ajkd.2011.02.387_bib61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2125.2007.03017.x","article-title":"The use of nationwide on-line prescription records improves the drug history in hospitalized patients","volume":"65","author":"Glintborg","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10.1053\/j.ajkd.2011.02.387_bib62","first-page":"751","article-title":"An exploratory comparison of medication lists at hospital admission with administrative database records","volume":"15","author":"Warholak","year":"2009","journal-title":"J Manag Care Pharm"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638611006901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638611006901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:57:26Z","timestamp":1759456646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638611006901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0272638611006901"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.02.387","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geographic Variation in Cardioprotective Antihypertensive Medication Usage in Dialysis Patients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.02.387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}